Skip to content

Efficacy and Safety Study of Auricular Point Acupressure for Gastrointestinal Dysfunction after Laparoscopic Cholecystectomy: A Single Center, Double-blind, Randomized and Controlled Pilot Trial.

Scientific Research Project on Traditional Chinese Medicine / Integrative Medicine of the Tianjin Health and Family Planning Commission

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15007643
Enrollment
Unknown
Registered
2015-12-14
Start date
2016-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Gastrointestinal Dysfunction

Interventions

Experimental Group:Auricular Point Acupressure at Da chang xue CO7
Control Group:Placebo

Sponsors

Tianjin Nankai Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years old; 2. Patients with the American Society of Anesthesiologists (ASA) physical status I - II undergoing elective general anesthesia LC surgery; 3. Patients had never used Auricular Point Acupressure; 4. During the same period, patients do not participate in any other clinical trials; 5. Without cognitive dysfunction, psychiatric diseases or aphasia, Communicating barrier-free, and volunteered to join this research and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnent women and lactating women; 2. Patients with history of abdominal surgery; 3. Not a single LC surgery; 4. Selected points at the skin is damaged by, Allergic to adhesive; 5. With severe gastrointestinal illness and chronic pain disorders (such as chronic pelvic pain, etc.), and long-term or in the past 48h oral analgesic drugs used; 6. With severe heart, brain, liver, kidney and hematopoietic system diseases; 7. With history of drug abuse (morphine, etc.), there are sports vomiting, vomiting surgery history, obesity (BMI> 80kg), diabetes or bedridden patients; 8. Patients convert to open surgery; 9. Patients who were included refuse to continue the treatment due to various reasons; 10. Serious complications occurred in the treatment process (such as peritonitis, biliary fistula), transferred to other specialist treatment, coma or death; 11. For any other reasons can not accept the follow-up; 12. The patients who do not meet the eligibility criteria have been strayed; 13. Poor compliance, Failing to treat or incomplete information, and affecting the efficacy assessment and safety evaluation.

Design outcomes

Primary

MeasureTime frame
The time of Passage of Flatus;

Secondary

MeasureTime frame
The time of Passage of Stool;Abdominal Distension;Abdominal Pain;Nausea;Vomiting;The Hospital Anxiety Depression Scale, HADS;the Gastrointestinal Quality of Life Index, GIQLI;

Countries

China

Contacts

Public ContactYandong Wang
nankaiyiyuan121@sina.cn+86 18698087121

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 1, 2026